Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

January 20, 2026

Study Completion Date

January 20, 2026

Conditions

ITP - Immune Thrombocytopenia

Interventions

DRUG

Eltrombopag

ITP patients will receive Eltrombopag and evulate occurance of liver disordres .

Trial Locations (1)

RECRUITING

Sohag university hospital, Sohag

All Listed Sponsors

lead

Sohag University

OTHER